
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [VRTX] Vertex Pharmaceuticals Inc.
Data updated 2025-Mar-10 (Monday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-Mar-10 Monday
Open | $483.39 | High | $503.89 +4.24% |
---|---|---|---|
Close | $500.01 | Low | $480.38 -0.62% |
Volume | 1.79 Million 0.99x | Volatility | 4.89% |
Change |
+$11.72
+2.40%
|
Streak | ↑ 2 days +2.94% |
20d SMA | $476.45 +4.9% | 50d SMA | $448.90 +11.4% | 100d SMA | $459.07 +8.9% | 200d SMA | $467.25 +7.0% |
RSI | 68 | MACD | 0.59 | ADX | 22.3 | Stochastic Oscillator | 83.9 84.7 |
CCI | 122.0 | ATR | 12.35 | OBV | 217 Million | Chaikin A/D | 467 Million |
Market Cap | 125 B | PEG Ratio | 1.35 | Trailing P/E | 29.5 | Forward P/E | 27.9 |
Price/Sales (ttm) | 11.4 | Price/Book (mrq) | 7.64 | EV/Revenue (ttm) | 11 | EV/EBITDA (ttm) | 249 |
% Held by Insiders | 0.11% | % Held by Institutions | 95.84% | Shares Short | 4.13 M | Shares Short (prior month) | 4.13 M |
Short Ratio | 3.77 | Short % of Outstanding | 1.61% | Short % of Float | 1.60% | Shares Short Change (mom) | 0.0% |
Revenue/Share (ttm) | $42.73 | Profit Margin (ttm) | -4.86% | Operating Margin (ttm) | 45.00% | EBITDA (ttm) | 4.77 B |
Diluted EPS (ttm) | $-2.10 | Current Ratio (mrq) | 3.99 | Return on Assets (ttm) | 12.70% | Return on Equity (ttm) | -3.15% |
Qtr Earnings Growth (yoy) | -5.60% | Qtr Revenue Growth (yoy) | 15.70% | Operating Cash Flow (ttm) | 3.54 B | Free Cash Flow (ttm) | 3.51 B |
Choose view type
Daily Performance for Vertex Pharmaceuticals Inc.. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Vertex Pharmaceuticals Inc. up to close of 2025-Mar-10 at $500.01
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+3.46%
|
-0.8%
|
+4.2%
|
5.0%
|
+2.0%
|
+1.9%
|
0.99x
|
02 Trailing 10-days
|
|
+3.81%
|
-0.8%
|
+5.6%
|
6.4%
|
+3.1%
|
+2.9%
|
0.98x
|
03 Trailing 20-days
|
|
+6.54%
|
-0.8%
|
+12.1%
|
13.0%
|
+4.9%
|
+4.6%
|
0.93x
|
04 Trailing 30-days
|
|
+13.74%
|
-0.8%
|
+16.1%
|
17.0%
|
+6.0%
|
+6.1%
|
1.00x
|
05 Trailing 50-days
|
|
+23.38%
|
-0.8%
|
+25.9%
|
26.8%
|
+11.4%
|
+7.7%
|
0.99x
|
06 Trailing 100-days
|
|
+3.80%
|
-3.8%
|
+32.3%
|
37.6%
|
+8.9%
|
+8.7%
|
1.13x
|
07 Trailing 200-days
|
|
+12.14%
|
-3.8%
|
+32.3%
|
37.6%
|
+7.0%
|
+10.3%
|
1.05x
|
08 Month-to-date
|
|
+4.21%
|
-0.8%
|
+4.7%
|
5.5%
|
|
|
|
09 Quarter-to-date
|
|
+24.16%
|
-0.8%
|
+25.9%
|
26.8%
|
|
|
|
10 Year-to-date
|
|
+24.16%
|
-0.8%
|
+25.9%
|
26.8%
|
|
|
|
11 Trailing 52-weeks
|
|
+20.90%
|
-3.8%
|
+32.3%
|
37.6%
|
|
|
|
3-month Performance Benchmarks for Vertex Pharmaceuticals Inc.:
Related to Vertex Pharmaceuticals Inc.
Information for Vertex Pharmaceuticals Inc.
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Mar-10 on Google
SEC Reports : Quarterly reports around 2025-Mar-10 on SEC Edgar
Compare Vertex Pharmaceuticals Inc. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Vertex Pharmaceuticals Inc.
Industry : Biotechnology industry performance which includes Vertex Pharmaceuticals Inc.